Dingkong Liang

No. 725, Wanping South Road
Xuhui, 200032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

DNA methylation-mediated silencing of MEOX1 promotes glycolysis and immune evasion in colorectal cancer cells through inhibition of GLP2R transcription.

DNA methylation-mediated silencing of MEOX1 promotes glycolysis and immune evasion in colorectal cancer cells through inhibition of GLP2R transcription.

Journal: Cell & bioscience
Published: August 31, 2025

Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?

Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining?

Journal: OncoTargets and therapy
Published: August 21, 2018

Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice.

Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice.

Journal: Molecular oral microbiology
Published: July 12, 2018

Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.

Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.

Journal: Annals of surgery
Published: January 16, 2018

MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125.

MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125.

Journal: International journal of cancer
Published: December 08, 2017

Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.

Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling.

Journal: Oncogene
Published: December 08, 2017

TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer.

TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer.

Journal: Cell death & disease
Published: October 22, 2017

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis.

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis.

Journal: OncoTargets and therapy
Published: October 06, 2017

Mismatch repair status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for pancreatic cancer.

Mismatch repair status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for pancreatic cancer.

Journal: Surgery
Published: September 05, 2017

Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?

Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?

Journal: Cellular and molecular life sciences : CMLS
Published: August 21, 2017

Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going.

Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going.

Journal: Experimental & molecular medicine
Published: May 15, 2017

FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.

FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.

Journal: Oncology reports
Published: January 11, 2017
Showing 1-12 of 22

Last Updated: 09/26/2026